Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Clinical trial NCT00365716 · COMPLETED

Trial details

NCT number: NCT00365716
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Papillomavirus Infections Genital Diseases, Female

Start date: 2000-05-01
Primary completion: 2004-05-01
Enrollment: 1158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.